These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38822143)

  • 1. Evaluation of Emulgel and Nanostructured Lipid Carrier-Based Gel Formulations for Transdermal Administration of Ibuprofen: Characterization, Mechanical Properties, and Ex-Vivo Skin Permeation.
    Yılmaz Usta D; Teksin ZS; Tugcu-Demiroz F
    AAPS PharmSciTech; 2024 May; 25(5):124. PubMed ID: 38822143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of ibuprofen-loaded nanostructured lipid carrier-based gels: characterization and investigation of in vitro and in vivo penetration through the skin.
    Sütő B; Berkó S; Kozma G; Kukovecz Á; Budai-Szűcs M; Erős G; Kemény L; Sztojkov-Ivanov A; Gáspár R; Csányi E
    Int J Nanomedicine; 2016; 11():1201-12. PubMed ID: 27099487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
    Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation Development, Characterization, and Evaluation of a Novel Dexibuprofen-Capsaicin Skin Emulgel with Improved In Vivo Anti-inflammatory and Analgesic Effects.
    Burki IK; Khan MK; Khan BA; Uzair B; Braga VA; Jamil QA
    AAPS PharmSciTech; 2020 Jul; 21(6):211. PubMed ID: 32737606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation, and physical, in vitro and ex vivo evaluation of transdermal ibuprofen hydrogels containing turpentine oil as penetration enhancer.
    Khan NR; Khan GM; Wahab A; Khan AR; Hussain A; Nawaz A; Akhlaq M
    Pharmazie; 2011 Nov; 66(11):849-52. PubMed ID: 22204130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization.
    Nagaich U; Gulati N
    Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation.
    Han F; Yin R; Che X; Yuan J; Cui Y; Yin H; Li S
    Int J Pharm; 2012 Dec; 439(1-2):349-57. PubMed ID: 22989987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation, optimization and evaluation of ibuprofen loaded menthosomes for transdermal delivery.
    Nayak D; Shetty MM; Halagali P; Rathnanand M; Gopinathan A; John J; Krishna Tippavajhala V
    Int J Pharm; 2024 Nov; 665():124671. PubMed ID: 39245088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
    Khurana S; Jain NK; Bedi PM
    Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanostructured Lipid Carriers (NLC)-Based Gel Formulations as Etodolac Delivery: From Gel Preparation to Permeation Study.
    Czajkowska-Kośnik A; Szymańska E; Winnicka K
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanostructured lipid carriers based nanogel for meloxicam delivery: mechanistic, in-vivo and stability evaluation.
    Khurana S; Jain NK; Bedi PM
    Drug Dev Ind Pharm; 2015; 41(8):1368-75. PubMed ID: 25151872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and biocompatibility evaluation of cutaneous formulations containing lipid nanoparticles.
    Eiras F; Amaral MH; Silva R; Martins E; Lobo JMS; Silva AC
    Int J Pharm; 2017 Mar; 519(1-2):373-380. PubMed ID: 28131849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of ibuprofen gel formulations using experimental design technique for enhanced transdermal penetration.
    Rhee YS; Chang SY; Park CW; Chi SC; Park ES
    Int J Pharm; 2008 Nov; 364(1):14-20. PubMed ID: 18755258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbopol 934, 940 and Ultrez 10 as viscosity modifiers of palm olein esters based nano-scaled emulsion containing ibuprofen.
    Abdullah GZ; Abdulkarim MF; Mallikarjun C; Mahdi ES; Basri M; Sattar MA; Noor AM
    Pak J Pharm Sci; 2013 Jan; 26(1):75-83. PubMed ID: 23261730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of nanostructured lipid carrier-based hydrogel for topical delivery of 5-fluorouracil.
    Rajinikanth PS; Chellian J
    Int J Nanomedicine; 2016; 11():5067-5077. PubMed ID: 27785014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced transdermal delivery of ketoprofen from bioadhesive gels.
    Singh S; Gajra B; Rawat M; Muthu MS
    Pak J Pharm Sci; 2009 Apr; 22(2):193-8. PubMed ID: 19339232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanical properties, skin permeation and in vivo evaluations of dexibuprofen-loaded emulsion gel for topical delivery.
    Jin SG; Yousaf AM; Son MW; Jang SW; Kim DW; Kim JO; Yong CS; Kim JH; Choi HG
    Arch Pharm Res; 2015 Feb; 38(2):216-22. PubMed ID: 24988989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanostructured lipid carriers loaded with Halobetasol propionate for topical treatment of inflammation: Development, characterization, biopharmaceutical behavior and therapeutic efficacy of gel dosage forms.
    Carvajal-Vidal P; González-Pizarro R; Araya C; Espina M; Halbaut L; Gómez de Aranda I; García ML; Calpena AC
    Int J Pharm; 2020 Jul; 585():119480. PubMed ID: 32479897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers.
    Abdel-Mottaleb MM; Neumann D; Lamprecht A
    Eur J Pharm Biopharm; 2011 Sep; 79(1):36-42. PubMed ID: 21558002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation.
    Mennini N; Cirri M; Maestrelli F; Mura P
    Int J Pharm; 2016 Dec; 515(1-2):684-691. PubMed ID: 27825863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.